THE CHEMO-SERO-THERAPEUTIC RES INST has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are THE CHEMO SERO THERAPEUTIC RES INSTITUTE, NAT INSTITUTE OF IMMUNOLOGY and CYTOTHERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | United States | 3 | |
#6 | Republic of Korea | 2 | |
#7 | Hong Kong | 1 | |
#8 | Mexico | 1 | |
#9 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Medical technology | |
#5 | Foods and drinks | |
#6 | Measurement | |
#7 | Macromolecular chemistry and polymers | |
#8 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Abe Motoharu | 6 |
#2 | Kishida Akio | 5 |
#3 | Higami Tetsuya | 5 |
#4 | Nakatake Hiroshi | 4 |
#5 | Onuma Hiroto | 4 |
#6 | Negishi Jun | 4 |
#7 | Kimura Tsuyoshi | 4 |
#8 | Tsurudome Yukari | 4 |
#9 | Funamoto Seiichi | 4 |
#10 | Hiwatari Ken-Ichiro | 4 |
Publication | Filing date | Title |
---|---|---|
WO2017122583A1 | Vaccine for hpv infections which contains hpvl2 peptide/hbs chimeric protein as active ingredient | |
WO2016143746A1 | Anti-adhesion material and artificial biological membrane each comprising decellularized tissue | |
CN106535928A | Vaccine containing virus-like particles |